A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial to Evaluate the Safety and Efficacy of Eculizumab in Patients with Relapsing Neuromyelitis Optica

Administered By

Awarded By

Contributors

Start/End

  • September 1, 2015 - October 9, 2017